Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TP0586532 is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk.
Description | TP0586532 is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk. |
Targets&IC50 | LpxC:0.101 μM |
In vitro | TP0586532 is an inhibitor of UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) with an IC50 of 0.101 μM[1]. |
Molecular Weight | 460.52 |
Formula | C26H28N4O4 |
CAS No. | 2427584-96-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (108.57 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TP0586532 2427584-96-9 Others Inhibitor low strains Bacterial TP 0586532 inhibit non-hydroxamate risk pneumoniae effective resistant cardiovascular TP-0586532 inhibitor